Hey there, bargain hunter.
Quantum computing has been Wall Street’s most reliably bipolar sector for the past two years. Stocks up 1,000%, then down 70%, then back up 100%. Valuations that look like typos. Insider selling that never stops. And yet, the money keeps flowing in.
Something changed in June. A new benchmark just arrived — and it is already reshuffling the pecking order.
The New Kid That Just Changed the Math
On June 3, 2026, Quantinuum (ticker: QNT) priced its IPO at $60 per share and raised $1.68 billion in gross proceeds in an upsized offering of 28,000,000 shares. The company, built from the 2021 combination of Honeywell Quantum Solutions and Cambridge Quantum, is now publicly traded on Nasdaq.
That IPO is forcing every investor in this sector to recalibrate.
Here is why. Before QNT, the public quantum market was dominated by companies that arrived through SPACs — often with less institutional credibility, thinner balance sheets, and more promotional roadmaps. Quantinuum came with a full prospectus and a Honeywell anchor: Honeywell retains roughly 49% of the combined voting power post-IPO. Quantinuum also points to enterprise and strategic relationships that include companies such as JPMorgan Chase and Amgen. It is trying to be the serious benchmark for the entire sector.
The question for existing holders of IONQ, RGTI, and QBTS: does QNT’s arrival make their positions better or worse?
The Financials Are Ugly Everywhere — Here Is the Difference That Matters
Let’s be direct about something. All four pure-play quantum names are pre-profit. All of them. No exceptions. This is a sector where the investment thesis is entirely about commercialization timelines that are still measured in years, not quarters.
Quantinuum reported $30.9 million in 2025 revenue, up about 35% from the prior year, while posting a net loss of $192.6 million. In Q1 2026, revenue was about $5.2 million — down about 73% year over year — and the net loss was $136.6 million. The revenue lumpiness is structural: contracts are large, irregular, and often tied to government programs and enterprise research budgets rather than smooth subscription curves.
Now compare that to IonQ. IonQ reported Q1 2026 revenue of $64.7 million. IonQ’s 2026 revenue guidance sits between $225 million and $245 million, implying roughly 70%+ year-over-year growth off its 2025 baseline. It also reported cash, cash equivalents, and investments of about $3.1 billion as of March 31, 2026. By the standards of this sector, that is a war chest.
Rigetti’s 2026 consensus revenue estimate implies triple-digit growth — from a tiny base — and a loss per share narrowing versus prior-year levels. The hardware is advancing too: Rigetti has disclosed an $8.4 million purchase order to deliver a 108-qubit system to India’s Centre for Development of Advanced Computing (C-DAC), with installation planned for the second half of 2026. But commercialization has not caught up with the technology. Until it does, Rigetti is a hardware story in a market that is increasingly demanding revenue proof.
D-Wave is the counterintuitive one. Q1 2026 revenue was $2.9 million — down 81% year over year — and the stock got punished for it. But look past the revenue line: bookings for the quarter rose 1,994% year over year to $33.4 million. That is future revenue in the pipeline. D-Wave also occupies a unique structural niche: it positions itself as the only dual-platform company, spanning both quantum annealing and gate-model systems, following its acquisition of Quantum Circuits. Its annealing systems are already being marketed into enterprise optimization use cases — while the rest of the sector is still building toward fault-tolerance. That commercial wedge is underappreciated.
Valuations That Should Give Anyone Pause
As of late May, IonQ, Rigetti, and D-Wave were trading at price-to-sales ratios of 109, 836, and 791, respectively. Since April 1, IonQ surged 110% while Rigetti climbed 58%, both significantly outperforming the S&P 500’s 14.5% gain over the same stretch. The QNT IPO acted as a fresh valuation anchor, drawing institutional capital toward names with credible technology roadmaps.
But the insider behavior tells a different story than the stock prices. Looking back over the past two years across the IonQ, Rigetti, and D-Wave trio, insider buying has been nearly nonexistent. IonQ had roughly $2.25 million in cumulative insider purchases over that period. D-Wave’s insider buying totaled $1,795. Rigetti has not had a single insider purchase.
That is worth sitting with for a minute.
The people who know these businesses best have not been buying the dip. That does not mean the thesis is wrong — insiders at early-stage technology companies often operate under trading restrictions and have illiquid concentrated positions. But it is a data point that belongs in any honest evaluation.
The Government Tailwind Is Real
This is where the picture gets more interesting for the bulls. In May 2026, Quantinuum disclosed it entered into a CHIPS Act letter of intent process with the U.S. Department of Commerce covering up to $100 million in proposed funding. Separately, the Department of Commerce (via NIST) announced letters of intent totaling $2.013 billion in planned CHIPS Act incentives across nine quantum companies, with IBM as the anchor recipient at $1 billion for a quantum foundry initiative and GlobalFoundries slated for $375 million. Public reporting around the program indicates the government is seeking minority, non-controlling equity stakes in recipients as part of the structure.
This is not grant money that disappears into R&D overhead. It is a structural validation that Washington is willing to push real industrial-policy muscle behind domestic quantum supply chains. For Quantinuum, it potentially reduces engineering and supply-chain risk in its roadmap. For IonQ — which also uses trapped-ion architecture — it is indirect validation that the trapped-ion path is getting serious attention at the federal level.
The Honest Framework for Positioning
Here is where I come down on this. The sector is not cheap by any conventional measure. These are all speculative, pre-profit, high-dilution investments where the return case depends almost entirely on whether commercialization milestones hit on schedule — and history with hyped early-stage technology is unforgiving when they do not.
That said: the QNT IPO matters because it has reset institutional expectations. It drew fresh capital into the sector. It is separating the companies with credible full-stack strategies from the ones coasting on hype. And it created a new public-market benchmark that makes IonQ — with its $64.7 million quarterly revenue, multi-billion-dollar liquidity, and 2026 growth guidance — look like the relative safety trade inside a very unsafe sector.
- IonQ (IONQ): The most commercially mature name. Highest near-term revenue visibility. Still unprofitable on an operating basis, but the path is clearer.
- D-Wave (QBTS): Underappreciated commercial wedge in enterprise optimization today. The 1,994% bookings surge deserves attention.
- Rigetti (RGTI): Hardware advancing but revenue lagging. For growth-oriented investors who can tolerate earlier-stage risk.
- Quantinuum (QNT): The cleanest traditional IPO in the sector’s history. Full-stack, Honeywell-anchored, and now a real benchmark. But it is still a story that asks investors to underwrite years of patience.
The part people skip in quantum: the market is valuing future disruption potential far more than current profitability. That means any missed milestone hits the stock harder than it would in a normal sector. Size your exposure accordingly. This is not a position you build in one trade.
What I am watching next: IonQ’s Q2 2026 earnings for the first test of whether that $225 to $245 million revenue guide is tracking. And whether Quantinuum’s results show Q1’s revenue dip was just timing noise. Those two numbers will tell you more about this sector than any press release about qubits.
This is not investment advice. All data sourced from SEC filings, company prospectuses, and publicly available analyst coverage as of June 26, 2026. Quantum computing stocks are highly speculative and involve significant risk of loss.
